Observational Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15805-15814
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15805
Table 1 Priorities and weights of performance measures for colorectal cancer using the analytic hierarchy process method
CategoryMeasureDescriptionGlobal priority1Weight2
Cohort 1Cohort 2Cohort 3
Pre-treatment (PT)PT1CRC patients with pre-operative chest X-ray and abdominal ultrasound, CT scan, or MRI0.1440.2130.1930.213
PT2Early stage of CRC0.1040.1540.1400.154
Treatment (T)T1CRC patients with history of surgical resection that were checked by colonoscopy or barium enema LGI series with sigmoidoscopy within six months peri-operatively0.0300.0440.0400.044
T2Patients with non-metastatic CRC offered curative resection or neoadjuvant therapy within six weeks of diagnosis0.0570.0840.0770.084
T3Patients with stage I to III CRC who underwent wide surgical resection with a “negative margin”0.1330.1970.1790.197
T4CRC patients who underwent surgery with pathology reports on tumor and node stage0.1160.1720.1560.172
T5Patients with stage I to III CRC with twelve or more lymph nodes examined in pathology reports0.0920.1360.1240.136
T6Patients (< 70 yr) with stage III CRC who received chemotherapy within eight weeks after surgery0.0690.093
Follow-up (F)3F1CRC patients (stages I–III) survived after five post-operative years0.101
F2RC patients (stages I–III) experienced no local recurrence after five post-operative years0.082
F3CRC patients expired within 30 d after surgery0.073
Sum of priorities (or weights)1.00141.0001.0001.000